| Literature DB >> 22466836 |
Toshinari Yagi1, Jun Ishikawa, Masahumi Takahashi, Yukiko Yamashita, Shinsuke Kusakabe, Tetsuhiro Yoshinami, Hiroaki Masaie, Naotoshi Sugimoto, Hitoshi Yoshida, Fumio Imamura.
Abstract
Myeloid sarcoma (MS) is a tumor consisting of myeloid blasts that occurs at an anatomical site other than the bone marrow. We report the case of a 38-year-old man with duodenal MS who underwent an allogeneic bone marrow transplant in a non-complete remission (CR) state. After the transplant, residual disease was suspected on a fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan, and additional radiotherapy resulted in CR, which has been maintained for 21 months. FDG-PET/CT scanning is useful for evaluating residual myeloid sarcoma during the peritransplant period.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22466836 DOI: 10.2169/internalmedicine.51.6652
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271